期刊文献+

非ST段抬高心肌梗死患者血清胱抑素C水平的影响因素分析 被引量:1

Infl uence factors of serum cystatin C level in patients with non-ST-segment elevation myocardial infarction
下载PDF
导出
摘要 目的探讨非ST段抬高心肌梗死(NSTEMI)患者血清胱抑素C(Cys-C)水平的影响因素。方法纳入74例NSTEMI患者,比较治疗前后血清Cys-C水平,关联分析Cys-C水平与一般资料和临床特征之间的关系。结果治疗后第10和30 d血清Cys-C水平显著升高(P均<0.05);饮酒史和治疗方式与治疗后血清Cys-C水平变化相关(P均<0.05),无饮酒史和选择介入治疗的患者,其治疗后血清Cys-C水平更高。结论血清Cys-C水平在NSTEMI发生时异常升高,经治疗后短期内继续升高,其变化受到饮酒史和治疗方式的影响。 【Objective】To explore the infl uence factors of serum cystatin C(Cys-C) level in patients with non-ST-segment elevation myocardial infarction(NSTEMI).【Methods】Seventy-four cases with NSTEMI were included, serum Cys-C levels before and after treatment were compared, and the correlations between Cys-C level with general information and clinical characteristics of patients were analyzed.【Results】Serum Cys-C levels were signifi cantly increased on the 10 th and 30 th day after treatment(P〈0.05); drinking history and methods of treatment were associated with serum Cys-C level(both P 0.05), patients without drinking history and treated by intervention had higher serum Cys-C level after treatment.【Conclusion】Serum Cys-C level is increased abnormally when NSTEMI occurs, and sequentially increased within a short-term period after treatment. The changes of serum Cys-C level is easily affected by drinking history and methods of treatment.
出处 《中国医学工程》 2016年第2期10-12,共3页 China Medical Engineering
关键词 胱抑素C 非ST段抬高心肌梗死 关联性 影响因素 cystatin C non-ST-segment elevation myocardial infarction association infl uence factor
  • 相关文献

参考文献5

二级参考文献47

  • 1冯建芳,汪淑荣,李平,赵一鸣,孙诠,师树古,陈明哲.急性心肌梗塞病人血清巯基蛋白酶抑制肽C的变化[J].基础医学与临床,1995,15(4):45-47. 被引量:20
  • 2Shi GP,Sukhova GK,Grubb A,et al.Cystatin C deficiency in human atherosclerosis and aortic aneurysms[J].J Clin Invest,1999,104:1191-1197.
  • 3Lindholt JS,Erlandsen EJ,Henneberg EW.Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms[J].Br J Surg,2001,88(11):1472-1475.
  • 4Sukhova GK,Wang B,Libby P,et al.Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apo-lipoprotein E-null mice[J].Circ Res,2005,96(3):368-375.
  • 5Bengtsson E,To F,Grubb A,et al.Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice[J].Atherosclerosis,2005,180:45-53.
  • 6Eriksson P,Deguchi H,Samnegard A,et al.Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease[J].Arterioscler Thromb Vasc Biol,2004,24:551-557.
  • 7Noto D,Cefalu' AB,Barbagallo CM,et al.Cystatin C levels are decreased in acute myocardial infarction,effect of cystatin C G73A gene polymorphism on plasma levels[J].Int J Cardiol,2005,101(2):213-217.
  • 8Luc G,Bard JM,Lesueur C.Plasma cystatin-C and development of coronary heart disease:The PRIME Study[J].Atherosclerosis,2006,85(2):375-380.
  • 9Koeni W,Twardella D,Brenner H,et al.Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events:more than simply a marker of glomerular filtration rate[J].Clin Chem,2005,51(2):321-532.
  • 10Jernberg T,Lindahl B,James S,et al.Cystatin C:a novel predictor of outcome in suspected or confirmed non-ST elevation acute coronary syndrome[J].Circulation,2004,110:2342-2348.

共引文献55

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部